(Q34503010)

2 August 2017

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial (English)

1 reference

2 August 2017

0 references

prevention of HIV/AIDS

0 references

cesarean section

0 references

vertical transmission

1 reference

1 reference

1 reference

0 references

European Mode of Delivery Collaboration

series ordinal

1

1 reference

PubMed ID

10199349

2 August 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

2 August 2017

1 reference

2 August 2017

353

1 reference

2 August 2017

1035-1039

1 reference

2 August 2017

9158

1 reference

Mechanisms and timing of mother-to-child transmission of HIV-1

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Risk factors for mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

The incidence of complications after caesarean section in 156 HIV-positive women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Postoperative cesarean section morbidity: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

A randomised trial of mode of delivery in women infected with the human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Prevention of vertical HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Mother-to-child transmission of human immunodeficiency virus in Italy: temporal trends and determinants of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2908084-2

7 January 2021

10.1016/S0140-6736(98)08084-2

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

10199349